Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
46
PRGO Quote, Financials, Valuation and Earnings
Last price:
$14.67
Seasonality move
:
-0.88%
Day range:
$14.48 - $14.91
52-week range:
$12.17 - $30.93
Dividend yield:
7.79%
P/E ratio:
--
P/S ratio:
0.48x
P/B ratio:
0.46x
Volume:
1.8M
Avg. volume:
2.2M
1-year change:
-39.96%
Market cap:
$2B
Revenue:
$4.4B
EPS (TTM):
-$0.38
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PRGO
Perrigo Co. Plc
|
$1.1B | $0.79 | 1.55% | 5557.8% | $21.00 |
|
ALKS
Alkermes Plc
|
$380.4M | $0.43 | 19.01% | 133.23% | $43.75 |
|
AMRN
Amarin Corp. Plc
|
$50.6M | $0.07 | 1.39% | -100% | $12.00 |
|
AVDL
Avadel Pharmaceuticals Plc
|
$79.2M | $0.21 | 48.49% | -76.67% | $21.83 |
|
JAZZ
Jazz Pharmaceuticals Plc
|
$1.2B | $6.51 | 10.99% | 109.38% | $219.40 |
|
SKYE
Skye Bioscience, Inc.
|
-- | -$0.31 | -- | -22.14% | $8.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PRGO
Perrigo Co. Plc
|
$14.89 | $21.00 | $2B | -- | $0.29 | 7.79% | 0.48x |
|
ALKS
Alkermes Plc
|
$32.00 | $43.75 | $5.3B | 15.83x | $0.00 | 0% | 3.53x |
|
AMRN
Amarin Corp. Plc
|
$15.72 | $12.00 | $326.8M | -- | $0.00 | 0% | 8.20x |
|
AVDL
Avadel Pharmaceuticals Plc
|
$21.64 | $21.83 | $2.1B | 299.90x | $0.00 | 0% | 8.56x |
|
JAZZ
Jazz Pharmaceuticals Plc
|
$169.59 | $219.40 | $10.3B | 15.09x | $0.00 | 0% | 2.49x |
|
SKYE
Skye Bioscience, Inc.
|
$0.78 | $8.25 | $25M | -- | $0.00 | 0% | 476.49x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PRGO
Perrigo Co. Plc
|
46.25% | 0.161 | 124.88% | 0.97x |
|
ALKS
Alkermes Plc
|
3.97% | 0.553 | 1.45% | 3.09x |
|
AMRN
Amarin Corp. Plc
|
1.45% | 2.914 | 1.98% | 2.35x |
|
AVDL
Avadel Pharmaceuticals Plc
|
27.56% | 0.412 | 2.52% | 2.14x |
|
JAZZ
Jazz Pharmaceuticals Plc
|
57.83% | 0.201 | 67.81% | 1.24x |
|
SKYE
Skye Bioscience, Inc.
|
0.97% | 6.090 | 0.26% | 4.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PRGO
Perrigo Co. Plc
|
$377.5M | $106.9M | -0.34% | -0.66% | 10.25% | $29.8M |
|
ALKS
Alkermes Plc
|
$341.2M | $89.1M | 20.4% | 22.16% | 22.6% | $84.4M |
|
AMRN
Amarin Corp. Plc
|
$21.2M | -$1.7M | -17.51% | -17.79% | -3.42% | -$12.8M |
|
AVDL
Avadel Pharmaceuticals Plc
|
$80.5M | $1.9M | -0.23% | -0.34% | 2.5% | $23.2M |
|
JAZZ
Jazz Pharmaceuticals Plc
|
$828.9M | $161.5M | -3.78% | -9.16% | 14.34% | $429.4M |
|
SKYE
Skye Bioscience, Inc.
|
-$178.9K | -$13.3M | -91.01% | -91.57% | -- | -$13.4M |
Perrigo Co. Plc vs. Competitors
-
Which has Higher Returns PRGO or ALKS?
Alkermes Plc has a net margin of 1.22% compared to Perrigo Co. Plc's net margin of 21%. Perrigo Co. Plc's return on equity of -0.66% beat Alkermes Plc's return on equity of 22.16%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co. Plc36.19% $0.05 $8.3B ALKSAlkermes Plc86.56% $0.49 $1.8B -
What do Analysts Say About PRGO or ALKS?
Perrigo Co. Plc has a consensus price target of $21.00, signalling upside risk potential of 41.03%. On the other hand Alkermes Plc has an analysts' consensus of $43.75 which suggests that it could grow by 36.72%. Given that Perrigo Co. Plc has higher upside potential than Alkermes Plc, analysts believe Perrigo Co. Plc is more attractive than Alkermes Plc.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co. Plc2 3 0 ALKSAlkermes Plc11 3 0 -
Is PRGO or ALKS More Risky?
Perrigo Co. Plc has a beta of 0.391, which suggesting that the stock is 60.882% less volatile than S&P 500. In comparison Alkermes Plc has a beta of 0.454, suggesting its less volatile than the S&P 500 by 54.612%.
-
Which is a Better Dividend Stock PRGO or ALKS?
Perrigo Co. Plc has a quarterly dividend of $0.29 per share corresponding to a yield of 7.79%. Alkermes Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co. Plc pays 94.9% of its earnings as a dividend. Alkermes Plc pays out -- of its earnings as a dividend. Perrigo Co. Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRGO or ALKS?
Perrigo Co. Plc quarterly revenues are $1B, which are larger than Alkermes Plc quarterly revenues of $394.2M. Perrigo Co. Plc's net income of $12.7M is lower than Alkermes Plc's net income of $82.8M. Notably, Perrigo Co. Plc's price-to-earnings ratio is -- while Alkermes Plc's PE ratio is 15.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co. Plc is 0.48x versus 3.53x for Alkermes Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co. Plc0.48x -- $1B $12.7M ALKSAlkermes Plc3.53x 15.83x $394.2M $82.8M
-
Which has Higher Returns PRGO or AMRN?
Amarin Corp. Plc has a net margin of 1.22% compared to Perrigo Co. Plc's net margin of -15.58%. Perrigo Co. Plc's return on equity of -0.66% beat Amarin Corp. Plc's return on equity of -17.79%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co. Plc36.19% $0.05 $8.3B AMRNAmarin Corp. Plc42.97% -$0.37 $465.6M -
What do Analysts Say About PRGO or AMRN?
Perrigo Co. Plc has a consensus price target of $21.00, signalling upside risk potential of 41.03%. On the other hand Amarin Corp. Plc has an analysts' consensus of $12.00 which suggests that it could fall by -23.86%. Given that Perrigo Co. Plc has higher upside potential than Amarin Corp. Plc, analysts believe Perrigo Co. Plc is more attractive than Amarin Corp. Plc.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co. Plc2 3 0 AMRNAmarin Corp. Plc0 1 1 -
Is PRGO or AMRN More Risky?
Perrigo Co. Plc has a beta of 0.391, which suggesting that the stock is 60.882% less volatile than S&P 500. In comparison Amarin Corp. Plc has a beta of 0.839, suggesting its less volatile than the S&P 500 by 16.111%.
-
Which is a Better Dividend Stock PRGO or AMRN?
Perrigo Co. Plc has a quarterly dividend of $0.29 per share corresponding to a yield of 7.79%. Amarin Corp. Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co. Plc pays 94.9% of its earnings as a dividend. Amarin Corp. Plc pays out -- of its earnings as a dividend. Perrigo Co. Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRGO or AMRN?
Perrigo Co. Plc quarterly revenues are $1B, which are larger than Amarin Corp. Plc quarterly revenues of $49.4M. Perrigo Co. Plc's net income of $12.7M is higher than Amarin Corp. Plc's net income of -$7.7M. Notably, Perrigo Co. Plc's price-to-earnings ratio is -- while Amarin Corp. Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co. Plc is 0.48x versus 8.20x for Amarin Corp. Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co. Plc0.48x -- $1B $12.7M AMRNAmarin Corp. Plc8.20x -- $49.4M -$7.7M
-
Which has Higher Returns PRGO or AVDL?
Avadel Pharmaceuticals Plc has a net margin of 1.22% compared to Perrigo Co. Plc's net margin of 0.03%. Perrigo Co. Plc's return on equity of -0.66% beat Avadel Pharmaceuticals Plc's return on equity of -0.34%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co. Plc36.19% $0.05 $8.3B AVDLAvadel Pharmaceuticals Plc90.66% $0.00 $135.6M -
What do Analysts Say About PRGO or AVDL?
Perrigo Co. Plc has a consensus price target of $21.00, signalling upside risk potential of 41.03%. On the other hand Avadel Pharmaceuticals Plc has an analysts' consensus of $21.83 which suggests that it could grow by 0.89%. Given that Perrigo Co. Plc has higher upside potential than Avadel Pharmaceuticals Plc, analysts believe Perrigo Co. Plc is more attractive than Avadel Pharmaceuticals Plc.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co. Plc2 3 0 AVDLAvadel Pharmaceuticals Plc0 4 0 -
Is PRGO or AVDL More Risky?
Perrigo Co. Plc has a beta of 0.391, which suggesting that the stock is 60.882% less volatile than S&P 500. In comparison Avadel Pharmaceuticals Plc has a beta of 1.314, suggesting its more volatile than the S&P 500 by 31.392%.
-
Which is a Better Dividend Stock PRGO or AVDL?
Perrigo Co. Plc has a quarterly dividend of $0.29 per share corresponding to a yield of 7.79%. Avadel Pharmaceuticals Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co. Plc pays 94.9% of its earnings as a dividend. Avadel Pharmaceuticals Plc pays out -- of its earnings as a dividend. Perrigo Co. Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRGO or AVDL?
Perrigo Co. Plc quarterly revenues are $1B, which are larger than Avadel Pharmaceuticals Plc quarterly revenues of $77.5M. Perrigo Co. Plc's net income of $12.7M is higher than Avadel Pharmaceuticals Plc's net income of $20K. Notably, Perrigo Co. Plc's price-to-earnings ratio is -- while Avadel Pharmaceuticals Plc's PE ratio is 299.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co. Plc is 0.48x versus 8.56x for Avadel Pharmaceuticals Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co. Plc0.48x -- $1B $12.7M AVDLAvadel Pharmaceuticals Plc8.56x 299.90x $77.5M $20K
-
Which has Higher Returns PRGO or JAZZ?
Jazz Pharmaceuticals Plc has a net margin of 1.22% compared to Perrigo Co. Plc's net margin of 22.33%. Perrigo Co. Plc's return on equity of -0.66% beat Jazz Pharmaceuticals Plc's return on equity of -9.16%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co. Plc36.19% $0.05 $8.3B JAZZJazz Pharmaceuticals Plc73.6% $4.08 $9.4B -
What do Analysts Say About PRGO or JAZZ?
Perrigo Co. Plc has a consensus price target of $21.00, signalling upside risk potential of 41.03%. On the other hand Jazz Pharmaceuticals Plc has an analysts' consensus of $219.40 which suggests that it could grow by 29.37%. Given that Perrigo Co. Plc has higher upside potential than Jazz Pharmaceuticals Plc, analysts believe Perrigo Co. Plc is more attractive than Jazz Pharmaceuticals Plc.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co. Plc2 3 0 JAZZJazz Pharmaceuticals Plc9 1 0 -
Is PRGO or JAZZ More Risky?
Perrigo Co. Plc has a beta of 0.391, which suggesting that the stock is 60.882% less volatile than S&P 500. In comparison Jazz Pharmaceuticals Plc has a beta of 0.260, suggesting its less volatile than the S&P 500 by 73.986%.
-
Which is a Better Dividend Stock PRGO or JAZZ?
Perrigo Co. Plc has a quarterly dividend of $0.29 per share corresponding to a yield of 7.79%. Jazz Pharmaceuticals Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co. Plc pays 94.9% of its earnings as a dividend. Jazz Pharmaceuticals Plc pays out -- of its earnings as a dividend. Perrigo Co. Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRGO or JAZZ?
Perrigo Co. Plc quarterly revenues are $1B, which are smaller than Jazz Pharmaceuticals Plc quarterly revenues of $1.1B. Perrigo Co. Plc's net income of $12.7M is lower than Jazz Pharmaceuticals Plc's net income of $251.4M. Notably, Perrigo Co. Plc's price-to-earnings ratio is -- while Jazz Pharmaceuticals Plc's PE ratio is 15.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co. Plc is 0.48x versus 2.49x for Jazz Pharmaceuticals Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co. Plc0.48x -- $1B $12.7M JAZZJazz Pharmaceuticals Plc2.49x 15.09x $1.1B $251.4M
-
Which has Higher Returns PRGO or SKYE?
Skye Bioscience, Inc. has a net margin of 1.22% compared to Perrigo Co. Plc's net margin of --. Perrigo Co. Plc's return on equity of -0.66% beat Skye Bioscience, Inc.'s return on equity of -91.57%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co. Plc36.19% $0.05 $8.3B SKYESkye Bioscience, Inc.-- -$0.32 $33.2M -
What do Analysts Say About PRGO or SKYE?
Perrigo Co. Plc has a consensus price target of $21.00, signalling upside risk potential of 41.03%. On the other hand Skye Bioscience, Inc. has an analysts' consensus of $8.25 which suggests that it could grow by 957.42%. Given that Skye Bioscience, Inc. has higher upside potential than Perrigo Co. Plc, analysts believe Skye Bioscience, Inc. is more attractive than Perrigo Co. Plc.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co. Plc2 3 0 SKYESkye Bioscience, Inc.4 2 0 -
Is PRGO or SKYE More Risky?
Perrigo Co. Plc has a beta of 0.391, which suggesting that the stock is 60.882% less volatile than S&P 500. In comparison Skye Bioscience, Inc. has a beta of 2.869, suggesting its more volatile than the S&P 500 by 186.859%.
-
Which is a Better Dividend Stock PRGO or SKYE?
Perrigo Co. Plc has a quarterly dividend of $0.29 per share corresponding to a yield of 7.79%. Skye Bioscience, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co. Plc pays 94.9% of its earnings as a dividend. Skye Bioscience, Inc. pays out -- of its earnings as a dividend. Perrigo Co. Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRGO or SKYE?
Perrigo Co. Plc quarterly revenues are $1B, which are larger than Skye Bioscience, Inc. quarterly revenues of --. Perrigo Co. Plc's net income of $12.7M is higher than Skye Bioscience, Inc.'s net income of -$12.8M. Notably, Perrigo Co. Plc's price-to-earnings ratio is -- while Skye Bioscience, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co. Plc is 0.48x versus 476.49x for Skye Bioscience, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co. Plc0.48x -- $1B $12.7M SKYESkye Bioscience, Inc.476.49x -- -- -$12.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
23
CAR alert for Feb 20
Avis Budget Group, Inc. [CAR] is down 2.23% over the past day.
Buy
75
HYMC alert for Feb 20
Hycroft Mining Holding Corp. [HYMC] is down 0.38% over the past day.
Sell
1
EPAM alert for Feb 20
EPAM Systems, Inc. [EPAM] is up 0.8% over the past day.
